Document Detail

Immune interventions of human diseases through toll-like receptors.
MedLine Citation:
PMID:  20047036     Owner:  NLM     Status:  MEDLINE    
Toll-like receptors (TLRs) are the immune sensors for infections, triggering robust innate immune activation followed by protective adaptive immunity against various infectious diseases. Recent evidence, however, has suggested that TLRs are involved in the pathogenesis of many diseases, including not only infectious diseases but also autoimmune diseases, allergy and atherosclerosis. Therefore, prophylactic or therapeutic application of TLR-based immune interventions should be potent, but their safety must be demonstrated using experimental animal models as well as human resources, including analysis of single nucleotide polymorphisms. Here, we focus on recent advances in understanding of the protective and pathogenic roles of TLRs in human diseases.
Cevayir Coban; Ken J Ishii; Shizuo Akira
Related Documents :
24494726 - Intracerebroventricular administration of streptozotocin as an experimental approach to...
25203436 - Chronic thromboembolic pulmonary hypertension: do not miss the chance for an early diag...
25417086 - Analysis of speech-based measures for detecting and monitoring alzheimer's disease.
9186136 - Uveitis as the only clinical manifestation of poststreptococcal syndrome.
9876956 - Clinical trial designs for demonstrating disease-course-altering effects in dementia.
14630196 - New concepts in the pathogenesis of atopic dermatitis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Advances in experimental medicine and biology     Volume:  655     ISSN:  0065-2598     ISO Abbreviation:  Adv. Exp. Med. Biol.     Publication Date:  2009  
Date Detail:
Created Date:  2010-01-04     Completed Date:  2010-08-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0121103     Medline TA:  Adv Exp Med Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  63-80     Citation Subset:  IM    
Department of Host Defense and 21st Century COE Program Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atherosclerosis / drug therapy,  immunology
Autoimmune Diseases / drug therapy,  immunology*
Drosophila melanogaster
Hypersensitivity / drug therapy,  immunology
Immune System
Models, Biological
Polymorphism, Single Nucleotide
Signal Transduction
Toll-Like Receptors / metabolism*
Reg. No./Substance:
0/Ligands; 0/Toll-Like Receptors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Shark novel antigen receptors-the next generation of biologic therapeutics?
Next Document:  Genome-based vaccine development: a short cut for the future.